Abstract:Vascular calcification is a common complication of endstage renal disease (ESRD), manifested as intimal and medial calcification of large arteries.1 It is associated with reduced arterial elasticity, cardiovascular events, and allcause mortality in patients who are on hemodialysis. Prior studies have identified several vascular calcification biomarkers, such as phosphate, osteoprotegerin (OPG), osteopontin (OPN), and fibroblast growth factor 23 (FGF23).2 However, none of them has been demonstrated as a clinically useful predictor in ESRD. Galectin-3 is a 29–35 kDa protein expressed by activated macrophages, neutrophils, and many other types of cells.3 It is associated with aortic valve calcification and arterial calcification in diabetes mellitus.4,5 Increased galectin-3 level was also observed in patients with peripheral artery disease.6 Here, we explored the association between serum galectin-3 and abdominal aortic calcification (AAC) in patients on maintenance hemodialysis. From June 2014 to January 2015, we enrolled 311 hemodialysis patients and performed a cross-sectional study to understand the associations between serum galectin-3 and various cardiovascular complications. This project was approved by the Ethics Committee of Renji Hospital, and written informed consent was obtained from all enrolled patients. Patients who underwent stable hemodialysis (three sessions a week for at least 3 months) were included for screening. Patients with any of the following conditions were excluded: heart failure (New York Heart Association Class III or IV or left ventricular ejection fraction < 40%), moderate or severe aortic valve stenosis, atrial fibrillation, secondor third-degree atrioventricular block, use of a pacemaker, recent myocardial infarction (MI) (⩽ 3 months), recent stroke (⩽ 3 months), recent transient ischemic attack (⩽ 3 months), pulseless extremity, malignancy, acute infectious diseases (⩽ 3 months), and those who refused to participate in this study. Blood samples were collected before the midweek dialysis session, and serum galectin-3 concentration was measured with an enzyme-linked immunosorbent assay (Human Galectin-3 Quantikine ELISA Kit; R&D Systems Inc., Minneapolis, MN, USA). The association between galectin-3 and arterial stiffness was reported elsewhere.7 Aortic calcification assessment was offered to a subset of the study group who agreed to participate in this subproject (n = 105, male = 61%, median age = 62 years, median dialysis duration = 79 months). We used a plain lateral lumbar radiograph to assess AAC. Calcific densities in the aorta at the level of the first through fourth lumbar vertebrae were graded on a 0 to 3 scale at each lumbar vertebra. The severity of AAC was categorized into tertiles based on the total aortic calcification score: no or mild (< 5 points), moderate (5–15 points), and severe (> 15 points).8,9 We found that as high as 74% of patients had moderate or severe AAC (moderate = 49, severe = 29). Serum galectin-3 concentration was significantly higher in those who had moderate or severe AAC (33.64 ± 11.41 vs 27.53 ± 9.74 ng/mL, p = 0.021). The optimal cut-off value of galectin-3 for the classification of AAC was 35.08 ng/mL, which was obtained based on the maximization of the Youden index. On the receiver operating characteristic (ROC) curve analysis, the area under the ROC curve was 0.654. Univariable logistic regression showed that a high galectin-3 level, increasing age, longer time since start of dialysis, and increased pulse pressure were associated with a high prevalence of moderate or severe AAC. These results were in line with prior studies.10,11 After adjusting for demographics and clinically relevant factors, including age, years on dialysis, pulse pressure, spKt/V for urea, C-reactive protein, and phosphorus, multivariable logistic regression showed the galectin-3 concentration (1 ng/mL Galectin-3 and abdominal aortic calcification in patients on hemodialysis

Predictive Value of Galectin-3 and Brachial-Ankle Pulse Wave Velocity for Coronary Artery Calcification in Coronary Arteriography Patients

Value Of Galectin-3 In The Diagnosis Of Acute Coronary Syndrome And The Assessment Of Coronary Artery Lesions

Association Between Plasma Lipoprotein Levels and Aortic Valve Calcification among Patients with Aortic Valve Replacement Surgery: A Retrospective Study

Prognostic Utility of Galectin-3 for Recurrent Cardiovascular Events During Long-term Follow-up in Patients with Stable Coronary Heart Disease: Results of the KAROLA Study

Correlation Between Non-Alcoholic Fatty Liver with Metabolic Risk Factors and Brachial-Ankle Pulse Wave Velocity

Galectin-3 and Abdominal Aortic Calcification in Patients on Hemodialysis

The predictive value of serum galectin 3 for abdominal aortic calcification in maintenance hemodialysis patients: A prospective cohort study

Thoracic Aortic Calcification and Carotid Atherosclerosis Prediction by Brachial-Ankle Pulse Wave Velocity

Predictive Value of Plasma Galectin-3 in Patients with Chronic Heart Failure

Positive Association of Serum Galectin-3 with the Development of Aortic Stiffness of Patients on Peritoneal Dialysis

High Serum Galectin-3 Level as a Potential Biomarker of Peripheral Artery Disease in Patients Undergoing Hemodialysis

Prognostic Value of Gai's Plaque Score and Agatston Coronary Artery Calcium Score for Functionally Significant Coronary Artery Stenosis.

The Predictive Value of Brachial-Ankle Pulse Wave Velocity in Coronary Atherosclerosis and Peripheral Artery Diseases in Urban Chinese Patients

[An Analysis of Clinical Factors for Coronary Artery Calcification Score].

The Brachial Ankle Pulse Wave Velocity is Associated with the Presence of Significant Coronary Artery Disease but Not the Extent

Relationship Between Blood Level of Galectin-3 and the Severity of Coronary Lesions in Patients With Coronary Artery Disease

Ankle Brachial Index is Associated with the Severity of Coronary Heart Disease

Brain-Derived Neurotrophic Factor, a New Predictor of Coronary Artery Calcification

Correlation between circulating long non-coding RNA growth arrest-specific transcript 5 and coronary artery calcification

Galectin-3 as a Biomarker for Stratifying Abdominal Aortic Aneurysm Size in a Taiwanese Population

Relation between brachial ankle pulse wave velocity and the severity of coronary artery